Basic Information
ID: ALA4322517
Type: ADME
Description: Drug level treated with 5-((R)-4-((R)-3-Methylmorpholino)-5a,6,8,9-tetrahydro-5H-pyrimido[5',4':4,5]pyrrolo[2,1-c][1,4]oxazin-2-yl)pyrimidin-2-amine assessed as recombinant human CYP1A1-mediated compound formation incubated for 60 mins by LC/MS analysis
Organism: Homo sapiens
Activity Charts
Bioactivity
Activity Types for Assay ALA4322517
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 383.41 | 0.13 | 0.13 |
| 385.43 | -0.34 | -0.34 |